Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis.
Cartland SP, Genner SW, Martínez GJ, Robertson S, Kockx M, Lin RC, O'Sullivan JF, Koay YC, Manuneedhi Cholan P, Kebede MA, Murphy AJ, Masters S, Bennett MR, Jessup W, Kritharides L, Geczy C, Patel S, Kavurma MM. Cartland SP, et al. Among authors: kritharides l. iScience. 2019 Feb 22;12:41-52. doi: 10.1016/j.isci.2018.12.037. Epub 2019 Jan 4. iScience. 2019. PMID: 30665196 Free PMC article.
Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
Dinnes DL, White MY, Kockx M, Traini M, Hsieh V, Kim MJ, Hou L, Jessup W, Rye KA, Thaysen-Andersen M, Cordwell SJ, Kritharides L. Dinnes DL, et al. Among authors: kritharides l. FASEB J. 2016 Dec;30(12):4239-4255. doi: 10.1096/fj.201600508R. Epub 2016 Sep 14. FASEB J. 2016. PMID: 27630170
Cleavage at Ser(228) is a novel, functionally important post-translational modification of apoA-I mediated by HMDMs that limits the antiatherogenic properties of apoA-I.-Dinnes, D. L. M., White, M. Y., Kockx, M., Traini, M., Hsieh, V., Kim, M.-J., Hou, L., Jessup, W …
Cleavage at Ser(228) is a novel, functionally important post-translational modification of apoA-I mediated by HMDMs that limits the antiathe …
Cholesterol efflux capacity: An introduction for clinicians.
Anastasius M, Kockx M, Jessup W, Sullivan D, Rye KA, Kritharides L. Anastasius M, et al. Among authors: kritharides l. Am Heart J. 2016 Oct;180:54-63. doi: 10.1016/j.ahj.2016.07.005. Epub 2016 Jul 14. Am Heart J. 2016. PMID: 27659883 Review.
Hyperlipidaemia in immunosuppression.
Kockx M, Kritharides L. Kockx M, et al. Among authors: kritharides l. Curr Opin Lipidol. 2016 Dec;27(6):631-632. doi: 10.1097/MOL.0000000000000363. Curr Opin Lipidol. 2016. PMID: 27805973 No abstract available.
318 results